Great case thank you for providing these! For practical offering of GDMT in hf-ref <40% is there a consensus on serial vs simultaneous offering of agents and the sequence of agent selection? Ive read through the results of the strong-hf and early results of the ongoing Netherlands titrate-hf study and a bunch of AHA papers and I'm more confused then ever on best possible gdmt sequencing. Patient context, renal function, blood pressure etc will obviously be key to selection for individualized plans. I just have it in the back of my mind to start SGLT2 early in the process as it can enhance tolerability of other GDMT.
Additional Course Module Information
eCourse Module
credits
April 10, 2025
There are no partners.
Mike Allan, MD CCFP
Jennifer Young, MD CCFP-EM
Émélie Braschi, MD PhD
Speakers do not have any conflicts of interest to declare.
Les auteurs n’ont aucun conflit d’intérêts à déclarer.
Reflective Learning Activity
1
2
3
4
5
6
Please provide any additional comments (optional).
Credit Submitted
Congratulations! Your credits will appear in Mainpro+ within 7 business days.
Browse through our collection of education tailored for family physicians. Watch videos, listen to podcasts, or read Tools for Practice articles. Choose the content that interests you the most.
Reflect on your knowledge by evaluating the activity. These activities serve to reinforce your understanding without being cumbersome, allowing you to quickly return to your busy day.
Once you've completed the learning activity, our system will automatically upload the certified credits you've earned to your Mainpro+® account. No need for manual entry - it's done seamlessly!
Well written
Great case thank you for providing these! For practical offering of GDMT in hf-ref <40% is there a consensus on serial vs simultaneous offering of agents and the sequence of agent selection? Ive read through the results of the strong-hf and early results of the ongoing Netherlands titrate-hf study and a bunch of AHA papers and I'm more confused then ever on best possible gdmt sequencing. Patient context, renal function, blood pressure etc will obviously be key to selection for individualized plans. I just have it in the back of my mind to start SGLT2 early in the process as it can enhance tolerability of other GDMT.